HB 3265 amends Oklahoma's police pension law to clarify disability benefit eligibility for law enforcement officers. It specifically expands the definition of "mental health specialist" to include licensed psychologists for disability certification (Section G). The bill establishes a clear benefit scale based on disability percentage (e.g., 50-74% impairment equals 75% of accrued retirement benefit) and presumes line-of-duty disability for officers exposed to hazardous substances like chemicals or blood-borne pathogens, unless proven otherwise (Section I). These changes directly affect Oklahoma police officers seeking disability benefits through the Oklahoma Police Pension and Retirement System.
HB 3644 (the Blake Burgess Act) requires hospitals with emergency departments and ambulatory surgical centers to implement standardized VTE (venous thromboembolism, or blood clot in veins) risk assessments for patients using nationally recognized tools and provide annual training to non-physician clinical staff. It mandates a statewide VTE registry managed by a private, nonprofit entity meeting specific criteria, which hospitals must report to starting July 2027 with data including patient age, zip code, sex, diagnosis details, and treatment. The registry collects information to improve VTE care quality, monitor outcomes, and inform state health reports, with hospitals required to submit data on VTE incidence, patient demographics, and treatment. The law directly affects hospitals, ambulatory surgical centers, and their clinical staff through new screening, training, and reporting obligations.
HB 3834, the "Oklahoma Breakthrough Therapy Act," establishes a framework for ibogaine clinical trials in Oklahoma. It requires drug developers to match state funding for trials, provide detailed plans for FDA approval and post-approval patient access (including priority for state residents and low-income care), and share intellectual property proceeds with the state. These proceeds fund an "Ibogaine Intellectual Property Account" managed by the State Treasurer, which must be spent on programs for at-risk populations with conditions treatable by ibogaine (like opioid use disorder). The bill also protects Oklahoma-licensed medical professionals from adverse licensing actions for recommending ibogaine therapy.
HB 3650 sets minimum reimbursement rates for healthcare providers treating Oklahoma Medicaid enrollees, requiring contracted entities to pay in-network providers 100% and out-of-network providers 90% of the 2021 fee schedule rates until 2035. It mandates value-based payment arrangements for providers (with quality-based incentives), requires 11% of contracted entities' healthcare spending to go toward primary care, and includes specific payment rules for rural health clinics, behavioral health centers, pharmacies, and ambulance services. The bill also establishes annual capitation rate updates and medical loss ratio penalties for non-compliant entities. It becomes effective November 1, 2026.
HB 4294 requires health insurers in Oklahoma to provide equal coverage for epilepsy as for other conditions, prohibiting termination or non-renewal of policies solely due to an epilepsy diagnosis. It mandates coverage for seizure prevention devices, surgeries, or medical procedures prescribed by an epilepsy specialist when medically necessary to reduce SUDEP (sudden unexpected death in epilepsy) risk. The law applies to all individual and group health insurance plans covering medical/surgical benefits and takes effect November 1, 2026. This directly affects epilepsy patients and insurers offering such coverage in Oklahoma.
HB 4275 standardizes certification rules for two mental health roles in Oklahoma: behavioral health case managers and peer recovery support specialists. It requires the Board of Mental Health and Substance Abuse Services to establish uniform education, exam, supervision, and continuing education standards for these professionals. The bill applies to individuals employed by state/local governments, contracted service providers, tribal facilities, or VA facilities, and restricts certified titles to these specific employment settings. Certification fees are capped at $100, and failure to comply with rules may result in suspension or revocation. The law takes effect November 1, 2026.
HB 1687 establishes Oklahoma's "Uniform Health Care Decisions Act of 2025," creating a clear framework for advance health care directives. It defines key terms like "advance health care directive" (including mental health directives), "agent" (someone appointed to make decisions), and "default surrogate" (a family member or cohabitant who can act if no directive exists). The bill specifies how directives are created, updated, or revoked, outlines duties for health care professionals, and details procedures for resolving conflicts between directives. This directly affects Oklahomans planning for future medical decisions, their families, and health care providers across the state.
HB 2749 creates a special fund called the Intergenerational Education Revolving Fund within the Oklahoma Health Care Authority. It establishes a competitive grant program to connect nursing facilities participating in Oklahoma's Medicaid program with public school districts for collaborative intergenerational education initiatives. Grant awards, provided as rate adjustments to qualifying facilities, will fund these partnerships. The program begins July 1, 2025, with funds limited to the total amount deposited into the revolving fund.
HB 3066 creates the Health Care Workforce Training Commission and establishes the "Rural Health Transformation Revolving Fund" in Oklahoma's state treasury. The fund will collect federal funds (including those from the One Big Beautiful Bill Act of 2025), interest, and designated state monies to specifically recruit and retain healthcare workers in rural and underserved Oklahoma communities, requiring a minimum 5-year service commitment. The Commission can use these funds for workforce programs and create necessary rules to implement the program. The bill takes effect July 1, 2026, and directly affects rural healthcare providers and communities facing workforce shortages.
HB 4454 restricts THC content and packaging for medical marijuana edibles in Oklahoma. It limits each serving to 10mg THC (100mg per package) and drinks to 20mg per container, while banning child-appealing designs, candy-like shapes, and color additives. Licensed processors must comply with these rules, submit monthly production/sales reports to the Oklahoma Medical Marijuana Authority, and undergo annual inspections. The bill directly affects medical marijuana processors who create edible products and takes effect November 1, 2026.
